Perioperative Pharmacology Flashcards
EMLA cream
Lidocaine with prilocaine topical analgesic
Omeprazole
gastric acid inhibitor (PPI)
Cyclizine
Anti-emetic (piperazine antiemetic)
Actrapid
short acting insulin
AMETOP
tetracaine topical analgesic
Ondansetron
5HT3 receptor antagonist
anti-emetic
Bupivacaine
long acting analgesic
Lisinopril
ACE-i
Metformin
anti-hyperglycaemic
Propofol
General anaesthetic
Lidocaine
short acting topical analgesic
Ranitidine
gastric acid inhibitor
H2 receptor antagonist
Temazepam
anxiolytic (sedation)
Morphine
mu opioid receptor agonist
Midazolam
anxiolytic (short acting)
Prochlorperazine
anti-emetic (phenothiazine)
Isoflurane
general anaesthetic
Lisinopril:
can safely be given in large doses in a hypertensive crisis
T/F
F
may induce refractory hypotension
Lisinopril:
may improve outcomes after MI
T/F
T
Lisinopril:
may cause an increase in plasma potassium
T/F
T
Lisinopril:
renal function and electrolytes should be checked before and during treatment with lisinopril
T/F
T
Lisinopril:
increases the rate of breakdown of angiotensin II
T/F
F
Mechanism of action of lisinopril
inhibits the conversion of angiotensin I to angiotensin II by ACE
Uses of ACE-i
HTN
all grades of HF
prophylaxis after MI
Salbutamol:
can produce hypokalaemia
T/F
T
stimulation of Na/K ATPase results in potassium shift into cells which can lead to hypokalemia
Salbutamol:
acts on the lungs only when given by the inhalational route
T/F
F
Salbutamol:
Induces bronchodilatation
T/F
T
Salbutamol:
is a beta-1 adrenoceptor agonist
T/F
F
beta-2